HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Yu Chen Selected Research

Neoplasms (Cancer)

1/2022METTL14-mediated m6A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p/AKT1S1 axis.
11/2021CircPTK2 inhibits the tumorigenesis and metastasis of gastric cancer by sponging miR-134-5p and activating CELF2/PTEN signaling.
10/2021Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma.
2/2021Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1/KDR/MMP9 and P53/BCL2L1/CASP3/7 pathways.
1/2021A Model Combining Skeletal Muscle Mass and a Hematological Biomarker to Predict Survival in Patients With Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy.
1/2021The m6A Reader YTHDF1 Facilitates the Tumorigenesis and Metastasis of Gastric Cancer via USP14 Translation in an m6A-Dependent Manner.
1/2021Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling.
1/20208-Chloro-Adenosine Inhibits Proliferation of MDA-MB-231 and SK-BR-3 Breast Cancer Cells by Regulating ADAR1/p53 Signaling Pathway.
1/2020Novel insights into the interplay between m6A modification and noncoding RNAs in cancer.
11/2019Sanguinarine inhibits the tumorigenesis of gastric cancer by regulating the TOX/DNA-PKcs/ KU70/80 pathway.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Yu Chen Research Topics

Disease

23Neoplasms (Cancer)
01/2022 - 08/2008
8Carcinogenesis
01/2022 - 08/2008
8Stomach Neoplasms (Stomach Cancer)
01/2022 - 08/2008
8Neoplasm Metastasis (Metastasis)
11/2021 - 08/2008
6Infections
01/2020 - 05/2012
5Inflammation (Inflammations)
04/2022 - 01/2008
5Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 06/2014
5Carcinoma (Carcinomatosis)
11/2017 - 02/2014
3Hepatocellular Carcinoma (Hepatoma)
10/2021 - 10/2002
3Melanoma (Melanoma, Malignant)
10/2019 - 05/2017
2Gastritis
04/2022 - 05/2005
2Necrosis
01/2022 - 01/2016
2Congenital Hypothyroidism (Cretinism)
07/2019 - 03/2018
2Adenoma (Adenomas)
06/2014 - 07/2013
2Experimental Arthritis
07/2013 - 01/2008
2Dyspepsia (Indigestion)
08/2011 - 05/2005
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022
1Muscular Diseases (Myopathy)
01/2022
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2022
1Trigeminal Neuralgia (Tic Douloureux)
10/2021
1Pain (Aches)
10/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2021
1Muscular Dystrophies (Muscular Dystrophy)
01/2021
1Nasopharyngeal Carcinoma
01/2021
1Intestinal Diseases (Diseases, Intestinal)
01/2021
1Intestinal Obstruction (Obstruction, Intestinal)
01/2021
1Lung Neoplasms (Lung Cancer)
01/2021
1Peripheral Nervous System Diseases (PNS Diseases)
11/2020
1Type 2 Diabetes Mellitus (MODY)
11/2020
1Aplastic Anemia (Anemia, Hypoplastic)
06/2020
1Tremor (Tremors)
01/2020
1Sepsis (Septicemia)
01/2020
1Critical Illness (Critically Ill)
01/2020
1Hemorrhagic Stroke
01/2020
1Ischemic Stroke
01/2020
1Skin Neoplasms (Skin Cancer)
10/2019

Drug/Important Bio-Agent (IBA)

5Biological ProductsIBA
01/2022 - 08/2008
5RNA (Ribonucleic Acid)IBA
10/2021 - 01/2018
5Proteins (Proteins, Gene)FDA Link
10/2021 - 08/2008
46-methyladenineIBA
01/2022 - 01/2019
4Therapeutic UsesIBA
10/2021 - 02/2011
4Pharmaceutical PreparationsIBA
01/2020 - 05/2012
3Circular RNAIBA
01/2022 - 01/2020
3DNA (Deoxyribonucleic Acid)IBA
11/2021 - 08/2008
3Messenger RNA (mRNA)IBA
10/2021 - 02/2014
3Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2017
3CateninsIBA
01/2021 - 11/2017
2Capsules (Microcapsules)IBA
04/2022 - 01/2021
2N-methyladenosineIBA
01/2022 - 01/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2019
2LipidsIBA
01/2022 - 01/2017
2Small Interfering RNA (siRNA)IBA
10/2021 - 01/2021
2artenimol (dihydroartemisinin)IBA
02/2021 - 01/2021
2Antimalarials (Antimalarial Agents)IBA
02/2021 - 01/2021
2Meropenem (Merrem)FDA LinkGeneric
01/2020 - 01/2020
2MicroRNAs (MicroRNA)IBA
01/2020 - 06/2014
2isoliquiritigenin (GU 17)IBA
01/2019 - 05/2017
2Anti-Bacterial Agents (Antibiotics)IBA
11/2018 - 09/2012
2FlavonoidsIBA
05/2017 - 01/2008
116S Ribosomal RNAIBA
04/2022
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2022
1Histones (Histone)IBA
01/2022
1NucleotidesIBA
01/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2022
1retinol dehydrogenaseIBA
01/2022
1CeramidesIBA
01/2022
1TOR Serine-Threonine KinasesIBA
01/2022
1sphingosine kinaseIBA
01/2022
1Protein Isoforms (Isoforms)IBA
10/2021
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
10/2021
1EndorphinsIBA
10/2021
1Interleukin-6 (Interleukin 6)IBA
10/2021
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
10/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021
1PhosphoenolpyruvateIBA
10/2021
1Caspase 3 (Caspase-3)IBA
02/2021
1Dystroglycans (Dystroglycan)IBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Retinaldehyde (Retinal)IBA
11/2020
1NAD (NADH)IBA
11/2020
1Fluorouracil (Carac)FDA LinkGeneric
06/2020
1Busulfan (Busulfex)FDA Link
06/2020
1Interleukin-4 (Interleukin 4)IBA
06/2020
1Interleukin-17 (Interleukin 17)IBA
06/2020
1Adenosine (Adenocard)FDA LinkGeneric
01/2020
1AntioxidantsIBA
11/2019
1BromidesIBA
11/2019
1AlkaloidsIBA
11/2019
1sanguinarineIBA
11/2019
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
11/2019
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
10/2019

Therapy/Procedure

3Therapeutics
01/2020 - 08/2011
2Radiotherapy
01/2021 - 10/2019
2Drug Therapy (Chemotherapy)
01/2021 - 01/2021
1Intraperitoneal Injections
01/2022
1Aftercare (After-Treatment)
10/2021
1Percutaneous Collagen Induction
10/2021
1Chemoradiotherapy
01/2021
1Activities of Daily Living (ADL)
01/2020